FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

X-Gen Pharmaceuticals Clonidine HCL Injection Recall

Clonidine HCL Injection, 1000 mcg/10mL (100 mcg/mL), 10 ML Single Dose Vial, Rx only, M…

X-Gen Pharmaceuticals Inc. · Horseheads, NY

Risk level
Class III
Reported by FDA
Apr 17, 2019
Recall ID
D-1084-2019
Check your lot numberHow we source this data

Summary

X-Gen Pharmaceuticals recalled Clonidine HCL Injection starting Mar 29, 2019. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-1084-2019 on Apr 17, 2019. Reason: Labeling: Label Error on Declared Strength: Side carton panel incorrectly lists the concentration as "500 mcg Clonidine Hydrochloride" rather than the correct concentration of "100 mcg Clonidine Hydrochloride" per mL. Status: Terminated.

Why it was recalled

Labeling: Label Error on Declared Strength: Side carton panel incorrectly lists the concentration as "500 mcg Clonidine Hydrochloride" rather than the correct concentration of "100 mcg Clonidine Hydrochloride" per mL.

Product description

Clonidine HCL Injection, 1000 mcg/10mL (100 mcg/mL), 10 ML Single Dose Vial, Rx only, Manufactured for: X-Gen Pharmaceuticals, Big Flats, NY 14814, NDC 39822-2000-1.

Lot numbers, UPCs & expiration codes

Lots #: PMXA1917, Exp 09/2020; PMXA1937, PMXA1938, Exp 11/2020;

Where it was sold

Nationwide in the USA.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1084-2019
Classification
Class III
Status
Terminated
Recall initiated
Mar 29, 2019
FDA report date
Apr 17, 2019
Quantity
24,966 vials
Recall type
Voluntary: Firm initiated
Recalling firm
X-Gen Pharmaceuticals Inc.

Original FDA data

Every field from FDA enforcement report D-1084-2019, exactly as published.

Show all FDA fields
City
Horseheads
State
NY
Status
Terminated
Country
United States
Event ID
82504
Address
300 Daniel Zenker Dr
Code information
Lots #: PMXA1917, Exp 09/2020; PMXA1937, PMXA1938, Exp 11/2020;
Postal code
14845-1014
Report date
Apr 17, 2019
Product type
Drugs
Recall number
D-1084-2019
Classification
Class III
Recalling firm
X-Gen Pharmaceuticals Inc.
Product quantity
24,966 vials
Termination date
Jun 2, 2021
Reason for recall
Labeling: Label Error on Declared Strength: Side carton panel incorrectly lists the concentration as "500 mcg Clonidine Hydrochloride" rather than the correct concentration of "100 mcg Clonidine Hydrochloride" per mL.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Clonidine HCL Injection, 1000 mcg/10mL (100 mcg/mL), 10 ML Single Dose Vial, Rx only, Manufactured for: X-Gen Pharmaceuticals, Big Flats, NY 14814, NDC 39822-2000-1.
Distribution pattern
Nationwide in the USA.
Recall initiation date
Mar 29, 2019
Initial firm notification
Letter
Center classification date
Apr 8, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1084-2019, published Apr 17, 2019. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls